FDA: Drugmakers have not made good on promised studies

04/24/2008 | Bloomberg1

A federal report found that drugmakers, as of Sept. 30, had not begun 1,044 post-market drug studies that they pledged to the FDA they would perform. Promises for 444 of them date back to Oct. 1, 2004, or earlier. A spokeswoman for the FDA said it will make sure that drug firms finish the incomplete post-approval trials "in a timely manner."

View Full Article in:

Bloomberg1

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD